![JMP | Free Full-Text | Modern Challenges for Early-Phase Clinical Trial Design and Biomarker Discovery in Metastatic Non-Small-Cell Lung Cancer JMP | Free Full-Text | Modern Challenges for Early-Phase Clinical Trial Design and Biomarker Discovery in Metastatic Non-Small-Cell Lung Cancer](https://www.mdpi.com/jmp/jmp-02-00018/article_deploy/html/images/jmp-02-00018-g001.png)
JMP | Free Full-Text | Modern Challenges for Early-Phase Clinical Trial Design and Biomarker Discovery in Metastatic Non-Small-Cell Lung Cancer
![Oncology Trials Outpacing Rest of the Field in Complexity and Duration, Study Shows | 2021-05-07 | CenterWatch Oncology Trials Outpacing Rest of the Field in Complexity and Duration, Study Shows | 2021-05-07 | CenterWatch](https://www.centerwatch.com/ext/resources/images/editorial/Oncology-360x240.png)
Oncology Trials Outpacing Rest of the Field in Complexity and Duration, Study Shows | 2021-05-07 | CenterWatch
![Current Oncology | Free Full-Text | CRAFT—A Proposed Framework for Decentralized Clinical Trials Participation in Canada Current Oncology | Free Full-Text | CRAFT—A Proposed Framework for Decentralized Clinical Trials Participation in Canada](https://www.mdpi.com/curroncol/curroncol-28-00329/article_deploy/html/images/curroncol-28-00329-g001-550.jpg)
Current Oncology | Free Full-Text | CRAFT—A Proposed Framework for Decentralized Clinical Trials Participation in Canada
![Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies - Annals of Oncology Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/4fbd2c57-dfa8-4450-b959-3e2174f9ad57/gr1.jpg)